Research and support

Cancer during pregnancy

Cancer affects 1 in 1000 pregnancies

Cancer during pregnancy is rare, affecting about 1 in 1,000 pregnancies. This translates to approximately 4,000 pregnant women diagnosed with cancer annually in Europe.

These women face complex challenges, including the need for accurate prognosis, understanding risks, and receiving safe and effective treatments for both themselves and their unborn children.

Uniting researchers & physicians to address this challenge

Since 2005, the International Network for Cancer, Infertility and Pregnancy (INCIP) has united researchers and physicians globally to address these challenges.

By focusing on improving outcomes through enhanced prognosis, risk assessment, and treatment options, INCIP ensures that pregnant women diagnosed with cancer receive the best possible care, safeguarding the health of both mothers and their children.

Patient testimonials

"Without this project, Victor probably wouldn't be here. We owe our happiness to this."
Monika
Mother of Victor
"With my story, I want to give courage to other women who are going through the same thing. I also do it to support the team in Leuven. Without them, my daughter and I might not be here now."
Isabelle
Mother of Anna
“In the name of all the children yet to be born and all the mothers who will be lying awake at night fearing for their children, this research is nothing less than an inspiration.”
Nadine
Mother of Rodrik

How we support you

Patients

Our research empowers you with the latest treatment options and support during your pregnancy. Explore resources, patient stories, and expert advice tailored to your needs.

Professionals

Stay informed on cutting-edge research and connect with a global network of healthcare providers. Access treatment guidelines, personalised advice, and professional development opportunities.

Researchers

Join our mission to advance the field of cancer treatment during pregnancy. Collaborate on groundbreaking studies, access extensive research databases, and contribute to pioneering projects.

© 2024 Amant Lab. All Rights Reserved.